Akt inhibition at the initial stage of CAR-T preparation enhances the CAR-positive expression rate, memory phenotype and in vivo efficacy.
Qing Zhang(South China University of Technology), Junnian Zheng(Xuzhou Medical College), Mengmeng Lü(Xuzhou Medical College), Qiang Fu(Binzhou Medical University), Jiage Ding(Xuzhou Medical College), Xiaohuan Wei(Xuzhou Medical College), Hongyan Liu(Queensland University of Technology), Shishuo Sun(Xuzhou Medical College), Xiaokang Zhang, Xiaoge Gao(Xuzhou Medical College)
PubMed
January 1, 2019
Cited by 44
Related Papers
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189
AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program
|The Journal of Experimental Medicine|2017|171
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
|Journal of Immunology Research|2018|152
HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular Carcinoma
|Molecular Cancer Research|2007|148